PCM
Penn Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Sell |
342,256
-31,263
| -8% | -$1.6M | 1.51% | 17 |
|
|
2025
Q1 | $16.9M | Buy |
373,519
+95,092
| +34% | +$4.29M | 1.64% | 12 |
|
|
2024
Q4 | $11.5M | Sell |
278,427
-30,817
| -10% | -$1.27M | 1.13% | 42 |
|
|
2024
Q3 | $12.1M | Buy |
309,244
+68,093
| +28% | +$2.66M | 1.11% | 42 |
|
|
2024
Q2 | $8.26M | Sell |
241,151
-4,545
| -2% | -$156K | 0.78% | 62 |
|
|
2024
Q1 | $6.18M | Sell |
245,696
-32
| -0% | -$805 | 0.55% | 71 |
|
|
2023
Q4 | $7.26M | Sell |
245,728
-242
| -0.1% | -$7.15K | 0.67% | 68 |
|
|
2023
Q3 | $7.78M | Buy |
245,970
+6,696
| +3% | +$212K | 0.8% | 62 |
|
|
2023
Q2 | $6.19M | Buy |
+239,274
| New | +$6.19M | 0.6% | 68 |
|